Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active compounds, particularly in pharmaceutical research. Its structure allows for selective functionalization of pyridine derivatives, making it valuable in the development of drug candidates targeting central nervous system disorders and oncology. The boronic acid group facilitates carbon-carbon bond formation under mild conditions, enhancing synthetic efficiency in heterocyclic chemistry. Commonly employed in medicinal chemistry for constructing pyridine-based scaffolds found in kinase inhibitors and receptor modulators.